Statistics
Publications
20
Citations
481
H-Index
14
Active since
2008
Linglan Tu is an author at Hangzhou Medical College specializing in oncology, pharmacology, and molecular oncology.
Publications per year
2008–2024
20
20
WBSCR22 confers oxaliplatin resistance in human colorectal cancer
Dongmei Yan, Linglan Tu, Haining Yuan et al. · Scientific Reports · 2017 · 50 citations · Full text
Medicine, Oncology, Pharmacology +17
Yawen Zhang, Linglan Tu, Yi Zhang et al. · Drug Delivery · 2021 · 30 citations · Full text
1–5 of 20